DOMINIC DEPHILLIPS: Open Payments
NPI 1780353813 · CHELAN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 77 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,567
Food & beverage: $1,377Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $772 |
| ABBVIE INC. | 30 | $474 |
| Amgen Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| GENZYME CORPORATION | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Lilly USA, LLC | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Incyte Corporation | 1 | $16 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, Otezla, TALTZ, COSENTYX, Rhapsido.
Industry payments across WA — which companies pay providers there.
